Site-dependent Response to Chemotherapy for Carcinoma of the Breast

Overview

Journal J R Soc Med

Specialty General Medicine

Date 1985 Jan 1

PMID 4045914

Citations 1

Authors

J M WHITEHOUSE

Affiliations

Soon will be listed here.

Citing Articles

Treating bony metastases.

Dodwell D, Howell A BMJ. 1991; 303(6800):429-30.

PMID: 1912831 PMC: 1670599. DOI: 10.1136/bmj.303.6800.429.

References

Gottlieb J, Rivkin S, Spigel S, Hoogstraten B, OBRYAN R, Delaney F . Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study. Cancer. 1974; 33(2):519-26. DOI: 10.1002/1097-0142(197402)33:2<519::aid-cncr2820330229>3.0.co;2-x. View

Vogel C, Smalley R, Raney M, Krauss S, Carpenter J, Velez-Garcia E . Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group project. J Clin Oncol. 1984; 2(6):643-51. DOI: 10.1200/JCO.1984.2.6.643. View

Creech R, Catalano R, Mastrangelo M, Engstrom P . An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer. Cancer. 1975; 35(4):1101-7. DOI: 10.1002/1097-0142(197504)35:4<1101::aid-cncr2820350413>3.0.co;2-m. View

Jones S, Durie B, Salmon S . Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer. Cancer. 1975; 36(1):90-7. DOI: 10.1002/1097-0142(197507)36:1<90::aid-cncr2820360104>3.0.co;2-h. View

Presant C, Van Amburg A, Klahr C . Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma. Cancer. 1977; 40(3):987-93. DOI: 10.1002/1097-0142(197709)40:3<987::aid-cncr2820400304>3.0.co;2-0. View

Mattsson W, Arwidi A, von Eyben F, LINDHOLM C . Phase II study of combined vincristine, adriamycin, cyclophosphamide, and methotrexate with citrovorum factor factor rescue in metastatic breast cancer. Cancer Treat Rep. 1977; 61(8):1527-31. View

Bull J, Tormey D, Li S, Carbone P, FALKSON G, Blom J . A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer. 1978; 41(5):1649-57. DOI: 10.1002/1097-0142(197805)41:5<1649::aid-cncr2820410501>3.0.co;2-j. View

Creech R, Catalano R, Harris D, Engstrom P, GROTZINGER P . Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin. Cancer. 1979; 43(1):51-9. DOI: 10.1002/1097-0142(197901)43:1<51::aid-cncr2820430107>3.0.co;2-n. View

Yap H, Benjamin R, Blumenschein G, Hortobagyi G, TASHIMA C, Buzdar A . Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer. Cancer Treat Rep. 1979; 63(1):77-83. View

10.

Swenerton K, Legha S, Smith T, Hortobagyi G, Gehan E, Yap H . Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res. 1979; 39(5):1552-62. View

11.

Decker D, Ahmann D, Bisel H, Edmonson J, Hahn R, OFallon J . Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysis. JAMA. 1979; 242(19):2075-9. View

12.

Manni A, Trujillo J, Pearson O . Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival. Cancer Treat Rep. 1980; 64(1):111-6. View

13.

Hancock B, TODD I, Wilkinson P . Chemotherapy of metastatic carcinoma of the breast. Clin Radiol. 1980; 31(4):433-6. DOI: 10.1016/s0009-9260(80)80184-x. View

14.

Hirshaut Y, Kesselheim H . Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity. Cancer. 1983; 51(11):1998-2004. DOI: 10.1002/1097-0142(19830601)51:11<1998::aid-cncr2820511107>3.0.co;2-u. View

15.

Legha S, Ajani J, Blumenschein G, Hortobagyi G, Buzdar A . Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio. Cancer. 1984; 53(9):1836-40. DOI: 10.1002/1097-0142(19840501)53:9<1836::aid-cncr2820530906>3.0.co;2-p. View

16.

Canellos G, DEVITA V, GOLD G, Chabner B, Schein P, Young R . Cyclical combination chemotherapy for advanced breast carcinoma. Br Med J. 1974; 1(5901):218-20. PMC: 1633086. DOI: 10.1136/bmj.1.5901.218. View